Immunological aspects of atherosclerosis

Clinical Science

Volumn 125, Issue 5, 2013, Pages 221-235

  Woollard, Kevin J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Immunology; Leucocyte biology; Macrophage; Monocyte

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; P SELECTIN GLYCOPROTEIN LIGAND 1; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ARTICLE; ATHEROSCLEROSIS; B LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CYTOKINE RELEASE; DENDRITIC CELL; HELPER CELL; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; KIDNEY FAILURE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; THROMBOCYTE; UPREGULATION;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; HUMANS; MONONUCLEAR PHAGOCYTE SYSTEM;

EID: 84878603606     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120576     Document Type: Article

References (200)

1. Dahlof, B. (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am. J. Cardiol. 105, 3A-9A
2. Lloyd-Jones, D. M. (2010) Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 12, 1768-1777
3. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695
4. Hahn, C. and Schwartz, M. A. (2009) Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 10, 53-62
5. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809
6. Kwon, G. P., Schroeder, J. L., Amar, M. J., Remaley, A. T. and Balaban, R. S. (2008) Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points. Circulation 117, 2919-2927
7. Millonig, G., Schwentner, C., Mueller, P., Mayerl, C. and Wick, G. (2001) The vascular-associated lymphoid tissue: a new site of local immunity. Curr. Opin. Lipidol. 12, 547-553
8. Wick, G., Knoflach, M. and Xu, Q. (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22, 361-403
9. Moore, K. J. and Tabas, I. (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355
10. Stoll, G. and Bendszus, M. (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37, 1923-1932
11. Mayerl, C., Lukasser, M., Sedivy, R., Niederegger, H., Seiler, R. and Wick, G. (2006) Atherosclerosis research from past to present-on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch. 449, 96-103
12. Methe, H. and Weis, M. (2007) Atherogenesis and inflammation-was Virchow right? Nephrol. Dial. Transplant. 22, 1823-1827
13. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126
14. Weber, C., Zernecke, A. and Libby, P. (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8, 802-815
15. Kzhyshkowska, J., Neyen, C. and Gordon, S. (2012) Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 217, 492-502
16. Greaves, D. R. and Gordon, S. (2009) The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J. Lipid Res. 50 (Suppl.), S282-S286
17. Steinman, R. M. and Cohn, Z. A. (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162
18. Koltsova, E. K. and Ley, K. (2011) How dendritic cells shape atherosclerosis. Trends Immunol. 32, 540-547
19. Andersson, J., Libby, P. and Hansson, G. K. (2010) Adaptive immunity and atherosclerosis. Clin. Immunol. 134, 33-46
20. Hansson, G. K. (2002) The B cell: a good guy in vascular disease? Arterioscler. Thromb. Vasc. Biol. 22, 523-524
21. Woollard, K. J. and Chin-Dusting, J. (2007) Therapeutic targeting of p-selectin in atherosclerosis. Inflamm. Allergy Drug Targets 6, 69-74
22. -/- mice. Am. J. Pathol. 177, 493-500
23. Eriksson, E. E., Xie, X., Werr, J., Thoren, P. and Lindbom, L. (2001) Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. 15, 1149-1157
24. Drechsler, M., Megens, R. T., van Zandvoort, M., Weber, C. and Soehnlein, O. (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122, 1837-1845
25. Eriksson, E. E. (2011) Intravital microscopy on atherosclerosis in apolipoprotein E-deficient mice establishes microvessels as major entry pathways for leukocytes to advanced lesions. Circulation 124, 2129-2138
26. Glass, C. K. and Olefsky, J. M. (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635-645
27. Geissmann, F., Auffray, C., Palframan, R., Wirrig, C., Ciocca, A., Campisi, L., Narni-Mancinelli, E. and Lauvau, G. (2008) Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 86, 398-408
28. Tacke, F. and Randolph, G. J. (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211, 609-618
29. Varol, C., Yona, S. and Jung, S. (2009) Origins and tissue-context-dependent fates of blood monocytes. Immunol. Cell Biol. 87, 30-38
30. Swirski, F. K., Pittet, M. J., Kircher, M. F., Aikawa, E., Jaffer, F. A., Libby, P. and Weissleder, R. (2006) Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. U.S.A. 103, 10340-10345
31. Patel, S. S., Thiagarajan, R., Willerson, J. T. and Yeh, E. T. (1998) Inhibition of α4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97, 75-81
32. Galkina, E. and Ley, K. (2009) Immune and inflammatory mechanisms of atherosclerosis (*) . Annu. Rev. Immunol. 27, 165-197
33. Stoneman, V., Braganza, D., Figg, N., Mercer, J., Lang, R., Goddard, M. and Bennett, M. (2007) Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100, 884-893
34. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M. and Ley, K. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661
35. Geissmann, F., Jung, S. and Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82
36. Gorgani, N. N., Ma, Y. and Clark, H. F. (2008) Gene signatures reflect the marked heterogeneity of tissue-resident macrophages. Immunol. Cell Biol. 86, 246-254
37. Cybulsky, M. I., Won, D. and Haidari, M. (2004) Leukocyte recruitment to atherosclerotic lesions. Can. J. Cardiol. 20 (Suppl. B), 24B-28B
38. Swirski, F. K., Weissleder, R. and Pittet, M. J. (2009) Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1424-1432
39. Trogan, E., Choudhury, R. P., Dansky, H. M., Rong, J. X., Breslow, J. L. and Fisher, E. A. (2002) Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 99, 2234-2239
40. Geissmann, F., Gordon, S., Hume, D. A., Mowat, A. M. and Randolph, G. J. (2010) Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 10, 453-460
41. Woollard, K. J. and Geissmann, F. (2010) Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7, 77-86
42. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G. and Geissmann, F. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670
43. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J., Liu, Y. J., MacPherson, G., Randolph, G. J. et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80
44. Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R. and Pittet, M. J. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195-205
45. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N. et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194
46. Murphy, A. J., Akhtari, M., Tolani, S., Pagler, T., Bijl, N., Kuo, C. L., Wang, M., Sanson, M., Abramowicz, S., Welch, C. et al. (2011) ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Invest. 121, 4138-4149
47. Yvan-Charvet, L., Pagler, T., Gautier, E. L., Avagyan, S., Siry, R. L., Han, S., Welch, C. L., Wang, N., Randolph, G. J., Snoeck, H. W. and Tall, A. R. (2010) ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328, 1689-1693
48. Varol, C., Landsman, L., Fogg, D. K., Greenshtein, L., Gildor, B., Margalit, R., Kalchenko, V., Geissmann, F. and Jung, S. (2007) Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204, 171-180
49. Combadiere, C., Potteaux, S., Rodero, M., Simon, T., Pezard, A., Esposito, B., Merval, R., Proudfoot, A., Tedgui, A. and Mallat, Z. (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649-1657
50. Wu, H., Gower, R. M., Wang, H., Perrard, X. Y., Ma, R., Bullard, D. C., Burns, A. R., Paul, A., Smith, C. W., Simon, S. I. and Ballantyne, C. M. (2009) Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119, 2708-2717
51. Dutta, P., Courties, G., Wei, Y., Leuschner, F., Gorbatov, R., Robbins, C. S., Iwamoto, Y., Thompson, B., Carlson, A. L., Heidt, T. et al. (2012) Myocardial infarction accelerates atherosclerosis. Nature 487, 325-329
52. Gordon, S. and Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964
53. Passlick, B., Flieger, D. and Ziegler-Heitbrock, H. W. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534
54. Strauss-Ayali, D., Conrad, S. M. and Mosser, D. M. (2007) Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82, 244-252
55. Weber, C., Belge, K. U., von Hundelshausen, P., Draude, G., Steppich, B., Mack, M., Frankenberger, M., Weber, K. S. and Ziegler-Heitbrock, H. W. (2000) Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67, 699-704
56. Auffray, C., Sieweke, M. H. and Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692
57. Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S. Y., Senechal, B., Puel, A., Biswas, S. K., Moshous, D., Picard, C. et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33, 375-386
58. Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F. et al. (2010) Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115, e10-e19
59. Haka, A. S., Potteaux, S., Fraser, H., Randolph, G. J. and Maxfield, F. R. (2012) Quantitative analysis of monocyte subpopulations in murine atherosclerotic plaques by multiphoton microscopy. PLoS ONE 7, e44823
60. Grau, A. J., Boddy, A. W., Dukovic, D. A., Buggle, F., Lichy, C., Brandt, T. and Hacke, W. (2004) Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35, 1147-1152
61. Nasir, K., Guallar, E., Navas-Acien, A., Criqui, M. H. and Lima, J. A. (2005) Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler. Thromb. Vasc. Biol. 25, 1966-1971
62. Horne, B. D., Anderson, J. L., John, J. M., Weaver, A., Bair, T. L., Jensen, K. R., Renlund, D. G. and Muhlestein, J. B. (2005) Which white blood cell subtypes predict increased cardiovascular risk? J. Am. Coll. Cardiol. 45, 1638-1643
63. Dragu, R., Khoury, S., Zuckerman, R., Suleiman, M., Mutlak, D., Agmon, Y., Kapeliovich, M., Beyar, R., Markiewicz, W., Hammerman, H. and Aronson, D. (2008) Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 196, 405-412
64. Gurm, H. S., Bhatt, D. L., Lincoff, A. M., Tcheng, J. E., Kereiakes, D. J., Kleiman, N. S., Jia, G. and Topol, E. J. (2003) Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 89, 1200-1204
65. Rana, J. S., Boekholdt, S. M., Ridker, P. M., Jukema, J. W., Luben, R., Bingham, S. A., Day, N. E., Wareham, N. J., Kastelein, J. J. and Khaw, K. T. (2007) Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J. Intern. Med. 262, 678-689
66. Rothe, G., Herr, A. S., Stohr, J., Abletshauser, C., Weidinger, G. and Schmitz, G. (1999) A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis 144, 251-261
67. + monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 2322-2330
68. + monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur. Heart J. 32, 84-92
69. + monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 73, 622-629
70. + monocytes in coronary artery disease and their relationship to serum TNF-a levels. Thromb. Haemost. 92, 419-424
71. Imanishi, T., Ikejima, H., Tsujioka, H., Kuroi, A., Ishibashi, K., Komukai, K., Tanimoto, T., Ino, Y., Takeshita, T. and Akasaka, T. (2010) Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Atherosclerosis 212, 628-635
72. Kashiwagi, M., Imanishi, T., Tsujioka, H., Ikejima, H., Kuroi, A., Ozaki, Y., Ishibashi, K., Komukai, K., Tanimoto, T., Ino, Y. et al. (2010) Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 212, 171-176
73. Liu, Y., Imanishi, T., Ikejima, H., Tsujioka, H., Ozaki, Y., Kuroi, A., Okochi, K., Ishibashi, K., Tanimoto, T., Ino, Y. et al. (2010) Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction. Circ. J. 74, 2585-2591
74. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314
75. Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B. et al. (2011) Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29, 1005-1010
76. Woollard, K. J. and Chin-Dusting, J. (2010) P-selectin antagonism in inflammatory disease. Curr. Pharm. Des. 16, 4113-411
77. Woollard, K. J., Suhartoyo, A., Harris, E. E., Eisenhardt, S. U., Jackson, S. P., Peter, K., Dart, A. M., Hickey, M. J. and Chin-Dusting, J. P. (2008) Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ. Res. 103, 1128-1138
78. Woollard, K. J., Kling, D., Kulkarni, S., Dart, A. M., Jackson, S. and Chin-Dusting, J. (2006) Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ. Res. 98, 149-156
79. Wolf, D., Hohmann, J. D., Wiedemann, A., Bledzka, K., Blankenbach, H., Marchini, T., Gutte, K., Zeschky, K., Bassler, N., Hoppe, N. et al. (2011) Binding of CD40L to Mac-1s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis-but does not affect immunity and thrombosis in mice. Circ. Res. 109, 1269-1279
80. Huo, Y., Hafezi-Moghadam, A. and Ley, K. (2000) Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res. 87, 153-159
81. Hashimoto, D., Miller, J. and Merad, M. (2011) Dendritic cell and macrophage heterogeneity in vivo. Immunity 35, 323-335
82. Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E., Pollard, J. W. et al. (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90
83. + DCs. J. Exp. Med. 206, 3115-3130
84. Miller, J. C., Brown, B. D., Shay, T., Gautier, E. L., Jojic, V., Cohain, A., Pandey, G., Leboeuf, M., Elpek, K. G., Helft, J. et al. (2012) Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13, 888-899
85. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35
86. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N. et al. (2007) PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143
87. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461
88. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686
89. Wilson, H. M., Chettibi, S., Jobin, C., Walbaum, D., Rees, A. J. and Kluth, D. C. (2005) Inhibition of macrophage nuclear factor-κB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am. J. Pathol. 167, 27-37
90. Martinez, F. O., Helming, L. and Gordon, S. (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483
91. Anderson, C. F. and Mosser, D. M. (2002) Cutting edge: biasing immune responses by directing antigen to macrophage Fc? receptors. J. Immunol. 168, 3697-3701
92. Mosser, D. M. and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
93. Komohara, Y., Hirahara, J., Horikawa, T., Kawamura, K., Kiyota, E., Sakashita, N., Araki, N. and Takeya, M. (2006) AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J. Histochem. Cytochem. 54, 763-771
94. Boyle, J. J., Harrington, H. A., Piper, E., Elderfield, K., Stark, J., Landis, R. C. and Haskard, D. O. (2009) Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 174, 1097-1108
95. Boyle, J. J., Johns, M., Kampfer, T., Nguyen, A. T., Game, L., Schaer, D. J., Mason, J. C. and Haskard, D. O. (2012) Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ. Res. 110, 20-33
96. Choudhury, R. P., Lee, J. M. and Greaves, D. R. (2005) Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. 2, 309-315
97. Gomez Perdiguero, E., Schulz, C. and Geissmann, F. (2013) Development and homeostasis of "resident" myeloid cells: the case of the microglia. Glia 61, 112-120
98. Chorro, L. and Geissmann, F. (2010) Development and homeostasis of 'resident' myeloid cells: the case of the Langerhans cell. Trends Immunol. 31, 438-445
99. Lipscomb, M. F. and Masten, B. J. (2002) Dendritic cells: immune regulators in health and disease. Physiol. Rev. 82, 97-130
100. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711
101. Heath, W. R., Belz, G. T., Behrens, G. M., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R. and Villadangos, J. A. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26
102. Gelin, C., Sloma, I., Charron, D. and Mooney, N. (2009) Regulation of MHC II and CD1 antigen presentation: from ubiquity to security. J. Leukoc. Biol. 85, 215-224
103. Randolph, G. J. and Potteaux, S. (2010) Vascular dendritic cells as gatekeepers of lipid accumulation within nascent atherosclerotic plaques. Circ. Res. 106, 227-229
104. Choi, J. H., Do, Y., Cheong, C., Koh, H., Boscardin, S. B., Oh, Y. S., Bozzacco, L., Trumpfheller, C., Park, C. G. and Steinman, R. M. (2009) Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206, 497-505
105. Bobryshev, Y. V. and Lord, R. S. (1995) Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta. Arch. Histol. Cytol. 58, 307-322
106. Bobryshev, Y. V. (2005) Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 26, 1700-1704
107. Niessner, A. and Weyand, C. M. (2010) Dendritic cells in atherosclerotic disease. Clin. Immunol. 134, 25-32
108. Bobryshev, Y. V. and Lord, R. S. (1998) Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc. Res. 37, 799-810
109. Bobryshev, Y. V., Taksir, T., Lord, R. S. and Freeman, M. W. (2001) Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice. Histol. Histopathol. 16, 801-808
110. Ozmen, J., Bobryshev, Y. V., Lord, R. S. and Ashwell, K. W. (2002) Identification of dendritic cells in aortic atherosclerotic lesions in rats with diet-induced hypercholesterolaemia. Histol. Histopathol. 17, 223-237
111. Jongstra-Bilen, J., Haidari, M., Zhu, S. N., Chen, M., Guha, D. and Cybulsky, M. I. (2006) Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073-2083
112. Hume, D. A. (2008) Macrophages as APC and the dendritic cell myth. J. Immunol. 181, 5829-5835
113. Gower, R. M., Wu, H., Foster, G. A., Devaraj, S., Jialal, I., Ballantyne, C. M., Knowlton, A. A. and Simon, S. I. (2011) CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler. Thromb. Vasc. Biol. 31, 160-166
114. Buono, C. and Lichtman, A. H. (2004) Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis. Trends Cardiovasc. Med. 14, 166-172
115. Shortman, K. and Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161
116. Gautier, E. L., Huby, T., Saint-Charles, F., Ouzilleau, B., Pirault, J., Deswaerte, V., Ginhoux, F., Miller, E. R., Witztum, J. L., Chapman, M. J. and Lesnik, P. (2009) Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 119, 2367-2375
117. Zhu, S. N., Chen, M., Jongstra-Bilen, J. and Cybulsky, M. I. (2009) GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206, 2141-2149
118. Kabashima, K., Banks, T. A., Ansel, K. M., Lu, T. T., Ware, C. F. and Cyster, J. G. (2005) Intrinsic lymphotoxin-β receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 22, 439-450
119. + T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ. Res. 103, 965-973
120. Llodra, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A. and Randolph, G. J. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U.S.A. 101, 11779-11784
121. Combadiere, C., Potteaux, S., Gao, J. L., Esposito, B., Casanova, S., Lee, E. J., Debre, P., Tedgui, A., Murphy, P. M. and Mallat, Z. (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107, 1009-1016
122. Liu, P., Yu, Y. R., Spencer, J. A., Johnson, A. E., Vallanat, C. T., Fong, A. M., Patterson, C. and Patel, D. D. (2008) CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 28, 243-250
123. Landsman, L., Bar-On, L., Zernecke, A., Kim, K. W., Krauthgamer, R., Shagdarsuren, E., Lira, S. A., Weissman, I. L., Weber, C. and Jung, S. (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113, 963-972
124. Buono, C., Pang, H., Uchida, Y., Libby, P., Sharpe, A. H. and Lichtman, A. H. (2004) B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 109, 2009-2015
125. Sun, J., Hartvigsen, K., Chou, M. Y., Zhang, Y., Sukhova, G. K., Zhang, J., Lopez-Ilasaca, M., Diehl, C. J., Yakov, N., Harats, D. et al. (2010) Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 122, 808-820
126. Choi, J. H., Cheong, C., Dandamudi, D. B., Park, C. G., Rodriguez, A., Mehandru, S., Velinzon, K., Jung, I. H., Yoo, J. Y., Oh, G. T. and Steinman, R. M. (2011) Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 35, 819-831
127. Koltsova, E. K., Garcia, Z., Chodaczek, G., Landau, M., McArdle, S., Scott, S. R., von Vietinghoff, S., Galkina, E., Miller, Y. I., Acton, S. T. and Ley, K. (2012) Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J. Clin. Invest. 122, 3114-3126
128. Andres, V., Pello, O. M. and Silvestre-Roig, C. (2012) Macrophage proliferation and apoptosis in atherosclerosis. Curr. Opin. Lipidol. 23, 429-438
129. Lahoute, C., Herbin, O., Mallat, Z. and Tedgui, A. (2011) Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat. Rev. Cardiol. 8, 348-358
130. Aubry, M. C., Riehle, D. L., Edwards, W. D., Maradit-Kremers, H., Roger, V. L., Sebo, T. J. and Gabriel, S. E. (2004) B-lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc. Pathol. 13, 233-236
131. Zhou, X. and Hansson, G. K. (1999) Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand. J. Immunol. 50, 25-30
132. Galkina, E., Kadl, A., Sanders, J., Varughese, D., Sarembock, I. J. and Ley, K. (2006) Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203, 1273-1282
133. Watanabe, M., Sangawa, A., Sasaki, Y., Yamashita, M., Tanaka-Shintani, M., Shintaku, M. and Ishikawa, Y. (2007) Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J. Atheroscler. Thromb. 14, 325-331
134. -/- mice. J. Exp. Med. 206, 233-248
135. Caligiuri, G., Nicoletti, A., Poirier, B. and Hansson, G. K. (2002) Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745-753
136. Shaw, P. X., Horkko, S., Chang, M. K., Curtiss, L. K., Palinski, W., Silverman, G. J. and Witztum, J. L. (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731-1740
137. Major, A. S., Fazio, S. and Linton, M. F. (2002) B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 22, 1892-1898
138. Lewis, M. J., Malik, T. H., Ehrenstein, M. R., Boyle, J. J., Botto, M. and Haskard, D. O. (2009) Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120, 417-426
139. Ait-Oufella, H., Herbin, O., Bouaziz, J. D., Binder, C. J., Uyttenhove, C., Laurans, L., Taleb, S., Van Vre, E., Esposito, B., Vilar, J. et al. (2010) B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207, 1579-1587
140. Kyaw, T., Tay, C., Khan, A., Dumouchel, V., Cao, A., To, K., Kehry, M., Dunn, R., Agrotis, A., Tipping, P. et al. (2010) Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185, 4410-4419
141. van Leeuwen, M., Damoiseaux, J., Duijvestijn, A. and Tervaert, J. W. (2009) The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis. Autoimmun. Rev. 9, 53-57
142. Tsimikas, S. (2006) Oxidized low-density lipoprotein biomarkers in atherosclerosis. Curr. Atheroscler. Rep. 8, 55-61
143. Palinski, W., Horkko, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K. and Witztum, J. L. (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98, 800-814
144. Binder, C. J., Chou, M. Y., Fogelstrand, L., Hartvigsen, K., Shaw, P. X., Boullier, A. and Witztum, J. L. (2008) Natural antibodies in murine atherosclerosis. Curr. Drug Targets 9, 190-195
145. -/- mice. J. Am. Coll. Cardiol. 50, 2313-2318
146. Hulthe, J., Wikstrand, J., Lidell, A., Wendelhag, I., Hansson, G. K. and Wiklund, O. (1998) Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 18, 1203-1211
147. Tornvall, P., Waeg, G., Nilsson, J., Hamsten, A. and Regnstrom, J. (2003) Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis 167, 347-353
148. Fredrikson, G. N., Hedblad, B., Berglund, G., Alm, R., Nilsson, J. A., Schiopu, A., Shah, P. K. and Nilsson, J. (2007) Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke 38, 1495-1500
149. Tsimikas, S., Brilakis, E. S., Lennon, R. J., Miller, E. R., Witztum, J. L., McConnell, J. P., Kornman, K. S. and Berger, P. B. (2007) Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48, 425-433
150. Boyle, J. J., Christou, I., Iqbal, M. B., Nguyen, A. T., Leung, V. W., Evans, P. C., Liu, Y., Johns, M., Kirkham, P. and Haskard, D. O. (2012) Solid-phase immunoglobulins IgG and IgM activate macrophages with solid-phase IgM acting via a novel scavenger receptor a pathway. Am. J. Pathol. 181, 347-361
151. Cancro, M. P. (2012) Editorial: phagocytic B cells: deja vu all over again? J. Leukoc. Biol. 91, 519-521
152. Allan, L. L., Hoefl, K., Zheng, D. J., Chung, B. K., Kozak, F. K., Tan, R. and van den Elzen, P. (2009) Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 114, 2411-2416
153. Afek, A., Harats, D., Roth, A., Keren, G. and George, J. (2004) Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice. Exp. Mol. Pathol. 76, 219-223
154. Tanigawa, T., Kitamura, A., Yamagishi, K., Sakurai, S., Nakata, A., Yamashita, H., Sato, S., Ohira, T., Imano, H., Shimamoto, T. and Iso, H. (2003) Relationships of differential leukocyte and lymphocyte subpopulations with carotid athersclerosis in elderly men. J. Clin. Immunol. 23, 469-476
155. Lund, F. E., Garvy, B. A., Randall, T. D. and Harris, D. P. (2005) Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8, 25-54
156. Tedgui, A. and Mallat, Z. (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86, 515-581
157. Hansson, G. K., Robertson, A. K. and Soderberg-Naucler, C. (2006) Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329
158. Gupta, S., Pablo, A. M., Jiang, X., Wang, N., Tall, A. R. and Schindler, C. (1997) IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752-2761
159. -/- mice. Am. J. Pathol. 157, 1819-1824
160. Buono, C., Come, C. E., Stavrakis, G., Maguire, G. F., Connelly, P. W. and Lichtman, A. H. (2003) Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23, 454-460
161. Mallat, Z., Ait-Oufella, H. and Tedgui, A. (2005) Regulatory T cell responses: potential role in the control of atherosclerosis. Curr. Opin. Lipidol. 16, 518-524
162. + T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 238, 247-262
163. Paulsson, G., Zhou, X., Tornquist, E. and Hansson, G. K. (2000) Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20, 10-17
164. Coller, B. S. (2005) Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25, 658-670
165. Gotsman, I., Grabie, N., Gupta, R., Dacosta, R., MacConmara, M., Lederer, J., Sukhova, G., Witztum, J. L., Sharpe, A. H. and Lichtman, A. H. (2006) Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114, 2047-2055
166. Mallat, Z., Gojova, A., Brun, V., Esposito, B., Fournier, N., Cottrez, F., Tedgui, A. and Groux, H. (2003) Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108, 1232-1237 167 Mallat, Z., Ait-Oufella, H. and Tedgui, A. (2007) Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc. Med. 17, 113-118
167. Mallat, Z., Ait-Oufella, H. and Tedgui, A. (2007) Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc. Med. 17, 113-118
168. de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M. and van der Wal, A. C. (2007) Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2, e779
169. + regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 893-900
170. + T cells in mice. Immunol. Cell Biol. 89, 130-142
171. Whitman, S. C. and Ramsamy, T. A. (2006) Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies. Can. J. Physiol. Pharmacol. 84, 67-75
172. Schiller, N. K., Boisvert, W. A. and Curtiss, L. K. (2002) Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lystbeige mutations. Arterioscler. Thromb. Vasc. Biol. 22, 1341-1346
173. Whitman, S. C., Rateri, D. L., Szilvassy, S. J., Yokoyama, W. and Daugherty, A. (2004) Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler. Thromb. Vasc. Biol. 24, 1049-1054
174. Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K., Meiler, S., Krohn, R., Schober, A., Sperandio, M., Soehnlein, O. et al. (2008) Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102, 209-217
175. Libby, P., Ridker, P. M. and Hansson, G. K. (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325
176. Yvan-Charvet, L., Welch, C., Pagler, T. A., Ranalletta, M., Lamkanfi, M., Han, S., Ishibashi, M., Li, R., Wang, N. and Tall, A. R. (2008) Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118, 1837-1847
177. Murphy, A. J., Woollard, K. J., Suhartoyo, A., Stirzaker, R. A., Shaw, J., Sviridov, D. and Chin-Dusting, J. P. (2011) Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 1333-1341
178. Soehnlein, O., Zernecke, A., Eriksson, E. E., Rothfuchs, A. G., Pham, C. T., Herwald, H., Bidzhekov, K., Rottenberg, M. E., Weber, C. and Lindbom, L. (2008) Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112, 1461-1471
179. Cole, J. E., Navin, T. J., Cross, A. J., Goddard, M. E., Alexopoulou, L., Mitra, A. T., Davies, A. H., Flavell, R. A., Feldmann, M. and Monaco, C. (2011) Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc. Natl. Acad. Sci. U.S.A. 108, 2372-2377
180. Papayannopoulos, V. and Zychlinsky, A. (2009) NETs: a new strategy for using old weapons. Trends Immunol. 30, 513-521
181. Megens, R. T., Vijayan, S., Lievens, D., Doring, Y., van Zandvoort, M. A., Grommes, J., Weber, C. and Soehnlein, O. (2012) Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb. Haemost. 107, 597-598
182. Massberg, S., Grahl, L., von Bruehl, M. L., Manukyan, D., Pfeiler, S., Goosmann, C., Brinkmann, V., Lorenz, M., Bidzhekov, K., Khandagale, A. B. et al. (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16, 887-896
183. Taylor, M. L. and Metcalfe, D. D. (2001) Mast cells in allergy and host defense. Allergy Asthma Proc. 22, 115-119
184. Cairns, A. and Constantinides, P. (1954) Mast cells in human atherosclerosis. Science 120, 31-32
185. Lappalainen, H., Laine, P., Pentikainen, M. O., Sajantila, A. and Kovanen, P. T. (2004) Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler. Thromb. Vasc. Biol. 24, 1880-1885
186. Mayranpaa, M. I., Heikkila, H. M., Lindstedt, K. A., Walls, A. F. and Kovanen, P. T. (2006) Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion. Coron. Artery Dis. 17, 611-621
187. Kokkonen, J. O. (1989) Stimulation of rat peritoneal mast cells enhances uptake of low density lipoproteins by rat peritoneal macrophages in vivo. Atherosclerosis 79, 213-223
188. Bot, I., de Jager, S. C., Zernecke, A., Lindstedt, K. A., van Berkel, T. J., Weber, C. and Biessen, E. A. (2007) Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115, 2516-2525
189. Zhang, T., Kurita-Ochiai, T., Hashizume, T., Du, Y., Oguchi, S. and Yamamoto, M. (2010) Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol. Med. Microbiol. 59, 143-151
190. Kovanen, P. T., Manttari, M., Palosuo, T., Manninen, V. and Aho, K. (1998) Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch. Intern. Med. 158, 1434-1439
191. -/- mice. J. Clin. Invest. 121, 3564-3577
192. Lee-Rueckert, M., Vikstedt, R., Metso, J., Jauhiainen, M. and Kovanen, P. T. (2008) Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase. J. Lipid Res. 49, 358-368
193. Lee, M., Metso, J., Jauhiainen, M. and Kovanen, P. T. (2003) Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-β-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells. J. Biol. Chem. 278, 13539-13545
194. Lievens, D. and von Hundelshausen, P. (2011) Platelets in atherosclerosis. Thromb. Haemost. 106, 827-838
195. Jackson, S. P. (2011) Arterial thrombosis-insidious, unpredictable and deadly. Nat. Med. 17, 1423-1436
196. Semple, J. W., Italiano, Jr, J. E. and Freedman, J. (2011) Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274
197. Devi, S., Kuligowski, M. P., Kwan, R. Y., Westein, E., Jackson, S. P., Kitching, A. R. and Hickey, M. J. (2010) Platelet recruitment to the inflamed glomerulus occurs via an αIIβ3/GPVI-dependent pathway. Am. J. Pathol. 177, 1131-1142
198. Yeaman, M. R. (2010) Platelets in defense against bacterial pathogens. Cell. Mol. Life Sci. 67, 525-544
199. Gawaz, M., Langer, H. and May, A. E. (2005) Platelets in inflammation and atherogenesis. J. Clin. Invest. 115, 3378-3384
200. Senzel, L., Gnatenko, D. V. and Bahou, W. F. (2009) The platelet proteome. Curr. Opin. Hematol. 16, 329-333